Aspirin found to stall prostate cancer progression

Men diagnosed with prostate cancer who took 3 aspirins a week had a 24% lower risk of developing lethal cancer, and a 39% reduced risk of dying from the disease.

"It was after the diagnosis that there appeared to be a benefit" says Christopher Allard a Urology fellow at Harvard Medical School lead author of the study.

A word of caution: be careful of gastro-intestinal problems with aspirin!